Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
TECHNICAL FIELD
The present invention relates to macrocycles having activity against the hepatitis C virus (HCV) and useful in the treatment of HCV infections. More particularly, the invention relates to C5-substituted, proline-derived, macrocyclic compounds, compositions containing such compounds
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
TECHNICAL FIELD
The present invention relates to novel bicyclic compounds having activity against the hepatitis C virus (HCV) and useful in the treatment of HCV infections. More particularly, the invention relates to bicyclic, C5-substituted proline derivatives, compositions containing such
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION
The present invention relates to novel hepatitis C virus ("HCV") protease inhibitors, pharmaceutical compositions containing one or more such inhibitors, methods of preparing such inhibitors and methods of using such inhibitors to treat hepatitis C and related disorders. This
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
2. TECHNICAL FIELD
The present disclosure relates to substantially stereomerically pure fused bicyclic proline compounds of structural Formulae II to VII:
##STR00002## in which A, M, M', and R.sup.5 are as described herein, to biocatalytic processes for their preparation, and to the biocatalytic
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION
The present invention relates to novel hepatitis C virus ("HCV") protease inhibitors, pharmaceutical compositions containing one or more such inhibitors, methods of preparing such inhibitors and methods of using such inhibitors to treat hepatitis C and related disorders. This
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
TECHNICAL FIELD
The present invention relates to a nucleic acid comprising a chimeric gene derived from hepatitis C viruses, a chimeric hepatitis C virus particle of the JFH-1 strain and a strain other than the JFH-1 strain (preferably a strain of genotype 1a, 1b, or 2a), a vector used for producing
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION
The present invention relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel peptides and analogues thereof, pharmaceutical compositions containing such peptides and methods for
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND
Hepatitis C virus (HCV) infection is estimated to affect 170 million individuals worldwide. This disease is primarily transmitted through contaminated blood products. Although its spread has been slowed as a result of improvement in blood screening in many countries, it remains the
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
JOINT RESEARCH AGREEMENT
Inventions described in this application were made by or on behalf of Enanta Pharmaceuticals, Inc. and Abbott Laboratories who are parties to a joint research agreement, that was in effect on or before the date such inventions were made and such inventions were made as a
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
JOINT RESEARCH AGREEMENT
Inventions described in this application were made by or on behalf of Enanta Pharmaceuticals, Inc. and Abbott Laboratories who are parties to a joint research agreement, that was in effect on or before the date such inventions were made and such inventions were made as a
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
TECHNICAL FIELD
The invention is directed to inhibitors of viral replication. In particular, it concerns the use of compounds related to the immunosuppressant macrolide FK506 to interfere with replication.
BACKGROUND ART
The macrolide FK506, which is of the formula: ##STR1## is manufactured by
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
TECHNICAL FIELD
The invention is directed to inhibitors of viral replication. In particular, it concerns the use of compounds related to the immunosuppressant macrolide FK506 to interfere with replication.
BACKGROUND ART
The macrolide FK506, which is of the formula: ##STR1## is manufactured by
Най-пълната база данни за лечебни билки, подкрепена от науката
Работи на 55 езика
Билкови лекове, подкрепени от науката
Разпознаване на билки по изображение
Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
Прочетете научни публикации, свързани с вашето търсене
Търсете лечебни билки по техните ефекти
Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите
Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва. * Цялата информация се базира на публикувани научни изследвания